Literature DB >> 26530259

The role of biopsy in the management of patients with presumed diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Brian T Ragel1, Timothy C Ryken2, Steven N Kalkanis3, Mateo Ziu4, Daniel Cahill5, Jeffrey J Olson6.   

Abstract

QUESTION: What is the optimal role of biopsy in the initial management of presumptive low-grade glioma in adults? TARGET POPULATION: Adult patients with imaging suggestive of a low-grade glioma. LEVEL III: Stereotactic biopsy is recommended when definitive surgical resection is limited by lesions that are deep-seated, not resectable, and/or located within eloquent cortex, or in patients unable to undergo craniotomy due to medical co-morbidities to obtain the critical tissue diagnosis needed for targeted treatment planning for patients with low-grade gliomas. QUESTION: What is the best technique for brain biopsy? TARGET POPULATION: Adult patients with imaging suggestive of a low-grade glioma. LEVEL III: Frameless and frame-based stereotactic brain biopsy for low-grade gliomas are recommended based on clinical circumstances as they provide similar diagnostic yield, diagnostic accuracy, morbidity, and mortality. It is recommended the surgeon consider advanced imaging techniques (e.g., perfusion, spectroscopy, metabolic studies) to target specific regions of interest to potentially improve diagnostic accuracy.

Entities:  

Keywords:  Biopsy; Guidelines; Low-grade glioma; Stereotactic biopsy

Mesh:

Year:  2015        PMID: 26530259     DOI: 10.1007/s11060-015-1866-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  64 in total

1.  Sources of error in neuropathology intraoperative diagnosis.

Authors:  Matthew Meyer; Julia Keith-Rokosh; Hasini Reddy; Joseph Megyesi; Robert R Hammond
Journal:  Can J Neurol Sci       Date:  2010-09       Impact factor: 2.104

2.  Stereotactic coregistration of 201Tl SPECT and MRI applied to brain tumor biopsies.

Authors:  Simone Hemm; Valérie Rigau; Jeanine Chevalier; Marie C Picot; Luc Bauchet; Hassan El Fertit; Marie-Ange Rodriguez; Laura Cif; Nathalie Vayssière; Michel Zanca; Pierre Baldet; François Segnarbieux; Philippe Coubes
Journal:  J Nucl Med       Date:  2005-07       Impact factor: 10.057

3.  CT-guided and computer assisted stereotactic biopsy. Technique, results, indications.

Authors:  J Voges; R Schröder; H Treuer; O Pastyr; W Schlegel; W J Lorenz; V Sturm
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

4.  The safety and diagnostic value of frame-based and CT-guided stereotactic brain biopsy technique.

Authors:  Mehmet Ersahin; Numan Karaaslan; Mehmet Sabri Gurbuz; Tayfun Hakan; Mehmet Zafer Berkman; Osman Ekinci; Nazım Denizli; Fugen Vardar Aker
Journal:  Turk Neurosurg       Date:  2011       Impact factor: 1.003

5.  Clinical validation of true frameless stereotactic biopsy: analysis of the first 125 consecutive cases.

Authors:  T S Paleologos; N L Dorward; J P Wadley; D G Thomas
Journal:  Neurosurgery       Date:  2001-10       Impact factor: 4.654

6.  Magnetic resonance-guided stereotactic biopsies: results in 100 consecutive cases.

Authors:  D Fontaine; D Dormont; D Hasboun; S Clemenceau; C Valery; C Oppenheim; M Sahel; C Marsault; J Philippon; P Cornu
Journal:  Acta Neurochir (Wien)       Date:  2000       Impact factor: 2.216

7.  Stereotactic biopsy of brain stem masses: Decision analysis and literature review.

Authors:  Uzma Samadani; Sherman Stein; Gul Moonis; Seema S Sonnad; Pia Bonura; Kevin D Judy
Journal:  Surg Neurol       Date:  2006-11

8.  FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.

Authors:  Gabriele Pöpperl; Friedrich W Kreth; Jan H Mehrkens; Jochen Herms; Klaus Seelos; Walter Koch; Franz J Gildehaus; Hans A Kretzschmar; Jörg C Tonn; Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-01       Impact factor: 9.236

9.  Frameless image-guided stereotaxy with real-time visual feedback for brain biopsy.

Authors:  Jens Gempt; Niels Buchmann; Yu-Mi Ryang; Sandro Krieg; Jürgen Kreutzer; Bernhard Meyer; Florian Ringel
Journal:  Acta Neurochir (Wien)       Date:  2012-07-31       Impact factor: 2.216

10.  Comparison of 18F-FDG and 11C-methionine for PET-guided stereotactic brain biopsy of gliomas.

Authors:  Benoit Pirotte; Serge Goldman; Nicolas Massager; Philippe David; David Wikler; Arlette Vandesteene; Isabelle Salmon; Jacques Brotchi; Marc Levivier
Journal:  J Nucl Med       Date:  2004-08       Impact factor: 10.057

View more
  12 in total

Review 1.  Guidelines in the management of CNS tumors.

Authors:  Navid Redjal; Andrew S Venteicher; Danielle Dang; Andrew Sloan; Remi A Kessler; Rebecca R Baron; Constantinos G Hadjipanayis; Clark C Chen; Mateo Ziu; Jeffrey J Olson; Brian V Nahed
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

2.  Comment on: the role of biopsy in the management of patients with presumed diffuse low grade glioma: a systematic review and evidence-based clinical practice guideline.

Authors:  Christoph Schwartz; Friedrich-Wilhelm Kreth
Journal:  J Neurooncol       Date:  2016-02-26       Impact factor: 4.130

Review 3.  Management of diffuse low-grade gliomas in adults - use of molecular diagnostics.

Authors:  Jan Buckner; Caterina Giannini; Jeanette Eckel-Passow; Daniel Lachance; Ian Parney; Nadia Laack; Robert Jenkins
Journal:  Nat Rev Neurol       Date:  2017-05-12       Impact factor: 42.937

Review 4.  What Have We Learned from Recent Clinical Studies in Low-Grade Gliomas?

Authors:  Roberta Rudà; Francesco Bruno; Riccardo Soffietti
Journal:  Curr Treat Options Neurol       Date:  2018-07-04       Impact factor: 3.598

5.  Readmission risk of malignant brain tumor patients undergoing laser interstitial thermal therapy (LITT) and stereotactic needle biopsy (SNB): a covariate balancing weights analysis of the National Readmissions Database (NRD).

Authors:  Truong H Do; Madeleine A Howard; Elise F Palzer; Jared D Huling; Mohammed A Alvi; Samuel W Cramer; Ping Zhu; Reid A Johnson; James Jean; Jinci Lu; Alec B Jonason; Jacob Hanson; Luke Sabal; Kevin W Sun; Robert A McGovern; Clark C Chen
Journal:  J Neurooncol       Date:  2022-07-23       Impact factor: 4.506

6.  What matters for people with brain cancer? Selecting clinical quality indicators for an Australian Brain Cancer Registry.

Authors:  Misa Matsuyama; Mythily Sachchithananthan; Robyn Leonard; Michael Besser; Anna K Nowak; Donna Truran; Claire M Vajdic; John R Zalcberg; Hui K Gan; Craig Gedye; Winny Varikatt; Eng-Siew Koh; Ganessan Kichenadasse; Hao-Wen Sim; Nicholas G Gottardo; Desma Spyridopoulos; Rosalind L Jeffree
Journal:  Neurooncol Pract       Date:  2021-08-31

7.  Assessment of accessibility to the diagnosis and treatment of brain tumors in Argentina: Preliminary results.

Authors:  Alejandra T Rabadán; Diego Hernandez; Néstor Vazquez; Rafael Torino; Blanco V Marcelo
Journal:  Surg Neurol Int       Date:  2017-06-13

Review 8.  The surgical perspective in precision treatment of diffuse gliomas.

Authors:  Niklas Thon; Joerg-Christian Tonn; Friedrich-Wilhelm Kreth
Journal:  Onco Targets Ther       Date:  2019-02-22       Impact factor: 4.147

Review 9.  Current Trends for Improving Safety of Stereotactic Brain Biopsies: Advanced Optical Methods for Vessel Avoidance and Tumor Detection.

Authors:  Serik K Akshulakov; Talgat T Kerimbayev; Michael Y Biryuchkov; Yermek A Urunbayev; Dara S Farhadi; Vadim A Byvaltsev
Journal:  Front Oncol       Date:  2019-10-02       Impact factor: 6.244

10.  Focused ultrasound for safe and effective release of brain tumor biomarkers into the peripheral circulation.

Authors:  Lifei Zhu; Arash Nazeri; Christopher Pham Pacia; Yimei Yue; Hong Chen
Journal:  PLoS One       Date:  2020-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.